Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) SEC filings
KNSA SEC filings moved a median of -1.06% by the close. KNSA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KNSA overview →
68 measured KNSA SEC filing events.
Where these KNSA SEC filings landedvs 67 measured KNSA SEC filing reactions
| Middle 50% of KNSA SEC filing reactions | -2.01% to +1.56% |
|---|---|
| Median reaction (to close) | -1.06% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 KNSA SEC filing events with a measured close landed between -2.01% and +1.56%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Kiniksa Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -2.20% | -0.63% | |
| Form 8-K Kiniksa Pharmaceuticals For: Jul 28 | SEC filing · Form 8-K | +6.21% | +12.94% | |
| Form 8-K Kiniksa Pharmaceuticals For: May 29 | SEC filing · Form 8-K | -0.21% | +1.23% | |
| Form 8-K Kiniksa Pharmaceuticals For: May 21 | SEC filing · Form 8-K | +0.74% | -1.65% | |
| Form 8-K Kiniksa Pharmaceuticals For: Apr 30 | SEC filing · Form 8-K | +0.47% | +5.26% | |
| Form 10-Q Kiniksa Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.76% | -1.71% | |
| Form 8-K Kiniksa Pharmaceuticals For: Apr 28 | SEC filing · Form 8-K | +5.27% | +15.06% | |
| Form ARS Kiniksa Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +0.25% | -1.10% | |
| Form DEF 14A Kiniksa Pharmaceuticals For: May 19 | SEC filing · Form DEF | +0.25% | -1.10% | |
| Form DEFA14A Kiniksa Pharmaceuticals | SEC filing · Form DEFA14A | +0.25% | -1.10% | |
| Form 10-K Kiniksa Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.94% | -1.70% | |
| Form 8-K Kiniksa Pharmaceuticals For: Feb 24 | SEC filing · Form 8-K | +5.57% | +1.75% | |
| Form S-8 Kiniksa Pharmaceuticals | SEC filing · Form S-8 | -0.94% | -1.70% | |
| Form 8-K Kiniksa Pharmaceuticals For: Jan 10 | SEC filing · Form 8-K | -1.50% | -4.15% | |
| Form 8-K Kiniksa Pharmaceuticals For: Jan 12 | SEC filing · Form 8-K | +2.01% | -7.10% | |
| Form 10-Q Kiniksa Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -2.14% | -4.86% | |
| Form 8-K Kiniksa Pharmaceuticals For: Oct 28 | SEC filing · Form 8-K | -9.88% | -4.48% | |
| Form 8-K Kiniksa Pharmaceuticals For: Sep 03 | SEC filing · Form 8-K | +0.94% | +4.35% | |
| Form 10-Q Kiniksa Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -0.07% | -2.50% | |
| Form 8-K Kiniksa Pharmaceuticals For: Jul 29 | SEC filing · Form 8-K | +2.21% | — | |
| Form 8-K Kiniksa Pharmaceuticals For: Jun 05 | SEC filing · Form 8-K | +0.31% | +2.64% | |
| Form 8-K Kiniksa Pharmaceuticals For: Jun 03 | SEC filing · Form 8-K | +0.75% | -1.06% | |
| Form DEFA14A Kiniksa Pharmaceuticals | SEC filing · Form DEFA14A | -2.20% | -2.58% | |
| Form DEFA14A Kiniksa Pharmaceuticals | SEC filing · Form DEFA14A | +1.77% | +3.23% | |
| Form 10-Q Kiniksa Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -0.08% | +3.65% | |
| Form 8-K Kiniksa Pharmaceuticals For: Apr 29 | SEC filing · Form 8-K | +10.93% | +16.42% | |
| Form 8-K Kiniksa Pharmaceuticals For: Apr 17 | SEC filing · Form 8-K | -1.86% | -2.10% | |
| Form ARS Kiniksa Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | +0.10% | -0.79% | |
| Form DEF 14A Kiniksa Pharmaceuticals For: Jun 03 | SEC filing · Form DEF | +0.10% | -0.79% | |
| Form DEFA14A Kiniksa Pharmaceuticals | SEC filing · Form DEFA14A | +0.10% | -0.79% | |
| Form PRE 14A Kiniksa Pharmaceuticals For: Jun 03 | SEC filing · Form PRE | -0.54% | +3.48% | |
| Form 10-K Kiniksa Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -0.07% | -1.40% | |
| Form 8-K Kiniksa Pharmaceuticals For: Feb 21 | SEC filing · Form 8-K | +3.75% | +2.71% | |
| Form S-8 Kiniksa Pharmaceuticals | SEC filing · Form S-8 | -0.07% | -1.40% | |
| Form 8-K Kiniksa Pharmaceuticals For: Jan 13 | SEC filing · Form 8-K | +2.57% | -0.77% | |
| Form 10-Q Kiniksa Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -0.73% | -1.25% | |
| Form 8-K Kiniksa Pharmaceuticals For: Oct 29 | SEC filing · Form 8-K | +9.99% | +9.12% | |
| Form 8-K Kiniksa Pharmaceuticals For: Oct 04 | SEC filing · Form 8-K | -0.92% | +2.26% | |
| Form 10-Q Kiniksa Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.08% | +0.58% | |
| Form 15-15D/A Kiniksa Pharmaceuticals | SEC filing · Form 15-15D | -0.46% | -3.08% | |
| Form 8-K Kiniksa Pharmaceuticals For: Jul 23 | SEC filing · Form 8-K | +0.93% | +13.07% | |
| Form EFFECT Kiniksa Pharmaceuticals | SEC filing · Form EFFECT | -0.53% | +1.57% | |
| Form EFFECT Kiniksa Pharmaceuticals | SEC filing · Form EFFECT | -1.41% | -2.54% | |
| Form 15-15D Kiniksa Pharmaceuticals | SEC filing · Form 15-15D | -1.41% | -2.54% | |
| Form 8-K12B Kiniksa Pharmaceuticals For: Jun 27 | SEC filing · Form 8-K12B | -1.41% | -2.54% | |
| Form POS AM Kiniksa Pharmaceuticals | SEC filing · Form POS | -1.41% | -2.54% | |
| Form POS AM Kiniksa Pharmaceuticals, | SEC filing · Form POS | +0.08% | +0.00% | |
| Form S-3 Kiniksa Pharmaceuticals | SEC filing · Form S-3 | -1.41% | -2.54% | |
| Form S-8 POS Kiniksa Pharmaceuticals | SEC filing · Form S-8 | -1.41% | -2.54% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Jun 25 | SEC filing · Form 8-K | -0.85% | -1.80% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Jun 14 | SEC filing · Form 8-K | -0.83% | -1.07% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Jun 05 | SEC filing · Form 8-K | -0.15% | -1.22% | |
| Form DEFA14A Kiniksa Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | -0.75% | |
| Form 10-Q Kiniksa Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.45% | +1.13% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Apr 23 | SEC filing · Form 8-K | +0.76% | +3.39% | |
| Form ARS Kiniksa Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.38% | -1.92% | |
| Form DEF 14A Kiniksa Pharmaceuticals, For: Jun 05 | SEC filing · Form DEF | +0.38% | -1.92% | |
| Form DEFA14A Kiniksa Pharmaceuticals, | SEC filing · Form DEFA14A | +0.38% | -1.92% | |
| Form PRE 14A Kiniksa Pharmaceuticals, For: Apr 10 | SEC filing · Form PRE | +0.11% | +0.40% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Apr 02 | SEC filing · Form 8-K | -0.72% | -4.00% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Mar 29 | SEC filing · Form 8-K | -0.84% | +0.30% | |
| Form DEFA14A Kiniksa Pharmaceuticals, | SEC filing · Form DEFA14A | -0.84% | +0.30% | |
| Form 10-K Kiniksa Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.26% | +1.54% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Feb 28 | SEC filing · Form 8-K | -5.57% | -7.12% | |
| Form S-8 Kiniksa Pharmaceuticals, | SEC filing · Form S-8 | -0.26% | +1.54% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Jan 04 | SEC filing · Form 8-K | -5.88% | -4.13% | |
| Form 10-Q Kiniksa Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +1.35% | -0.61% | |
| Form 8-K Kiniksa Pharmaceuticals, For: Oct 31 | SEC filing · Form 8-K | -0.94% | +2.35% |
Keep exploring
More KNSA: earnings → · analyst actions → · KNSA overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| LeMaitre Vascular, Inc. (LMAT) | 430 | +0.05% | 54% |
| TRULIEVE CANNABIS CORP (TCNNF) | 429 | +0.41% | 58% |
| Veracyte, Inc. (VCYT) | 427 | -0.15% | 46% |
| Moleculin Biotech, Inc. (MBRX) | 426 | -0.21% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.